Icon PLC
ICLR
Company Profile
Business description
Icon is a global late-stage contract research organization that provides drug development and clinical trial services to pharmaceutical, biotechnology, and medical-device firms. While the vast majority of its revenue comes from clinical research, Icon also offers ancillary services such as laboratory and imaging capabilities. The company is headquartered in Ireland.
Contact
South County Business Park
Leopardstown
DublinD18 X5R3
IRLT: +353 12912000
Sector
Healthcare
Stock type
Defensive
Industry
Diagnostics & Research
Fiscal Year End
31 December 2025
Employees
39,800
Icon PLC News & Analysis
stocks
Finding bargains in global small to mid-cap stocks
Medical scopes, orthodontics, pet care and groceries have proved fertile ground for Bell Asset Management.
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 9,182.50 | 24.00 | 0.26% |
| CAC 40 | 8,104.91 | 16.16 | -0.20% |
| DAX 40 | 24,007.58 | 49.28 | 0.21% |
| Dow JONES (US) | 47,562.87 | 40.75 | 0.09% |
| FTSE 100 | 9,737.81 | 20.56 | 0.21% |
| HKSE | 26,153.54 | 246.89 | 0.95% |
| NASDAQ | 23,724.96 | 143.81 | 0.61% |
| Nikkei 225 | 52,411.34 | 1,085.73 | 2.12% |
| NZX 50 Index | 13,556.30 | 7.98 | 0.06% |
| S&P 500 | 6,840.20 | 17.86 | 0.26% |
| S&P/ASX 200 | 8,894.80 | 36.20 | 0.41% |
| SSE Composite Index | 3,976.52 | 21.73 | 0.55% |